All Stories

  1. A toolbox to visually explore cerebellar shape changes in cerebellar disease and dysfunction
  2. In vivo imaging of neurodegeneration in dementia with Lewy bodies (DLB)
  3. Landmark based shape analysis for cerebellar ataxia classification and cerebellar atrophy pattern visualization
  4. Emerging therapies in Friedreich's ataxia
  5. Survival in Frontotemporal Dementia Phenotypes: A Meta-Analysis
  6. Caregiver burden in atypical dementias: comparing frontotemporal dementia, Creutzfeldt–Jakob disease, and Alzheimer's disease
  7. Comment: Toward a physiology of eating disorder in frontotemporal dementia
  8. Comparisons of trajectories of mmse and moca scores in frontotemporal dementia and Alzheimer’s disease
  9. Longitudinal analysis of electronic messages to characterize language decline in ftd-als
  10. Odor identification in frontotemporal dementia, Alzheimer’s disease, and major depression
  11. Advancing research and treatment of frontotemporal lobar degeneration (ARTFL): Preparing for clinical trials for ftld in north america
  12. Young-Onset Dementias
  13. The Practice and Science of Young-Onset Dementias
  14. Young-Onset Dementia Epidemiology Applied to Neuropsychiatry Practice
  15. Caregiver Burden in Prion Disease as Compared to Frontotemporal Dementia and Alzheimer Disease
  16. Hippocampal sclerosis dementia with the C9ORF72 hexanucleotide repeat expansion
  17. In young men, various risk factors are associated with later development of young-onset dementia
  18. The impact of complex chronic diseases on care utilization among assisted living residents
  19. Neuropsychiatric symptoms in Alzheimer's disease: Past progress and anticipation of the future
  20. Frontotemporal dementia and psychiatry
  21. The epidemiology of frontotemporal dementia
  22. Management of frontotemporal dementia in mental health and multidisciplinary settings
  23. Genome-wide scan of healthy human connectome discovers SPON1 gene variant influencing dementia severity
  24. Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial
  25. 12-month incidence, prevalence, persistence, and treatment of mental disorders among individuals recently admitted to assisted living facilities in Maryland
  26. Childless Elders in Assisted Living: Findings from the Maryland Assisted Living Study
  27. A randomized, multicenter, placebo controlled trial of memantine for behavioral variant FTD and semantic variant PPA
  28. Characteristics of Behavior-Variant Frontotemporal Dementia (FTD) across the Lifespan (P05.066)
  29. Psychiatric barriers and the international AIDS epidemic
  30. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
  31. Determinants of survival in autopsy-confirmed patients with behavioral variant frontotemporal dementia (bvFTD): Second Report of the international bvFTD criteria consortium (FTDC)
  32. What Is the Life Expectancy in Frontotemporal Lobar Degeneration?
  33. The physical environment influences neuropsychiatric symptoms and other outcomes in assisted living residents
  34. Correlates of Functional Dependence Among Recently Admitted Assisted Living Residents With and Without Dementia
  35. Personality disorder traits as predictors of subsequent first-onset panic disorder or agoraphobia
  36. Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders
  37. Characteristics of Established and Proposed Sporadic Creutzfeldt-Jakob Disease Variants
  38. The Spectrum of Medical Illness and Medication Use Among Residents of Assisted Living Facilities in Central Maryland
  39. Neuroleptic discontinuation during dementia care: a recent trial and its implications for practice
  40. Early Detection of Periodic Sharp Wave Complexes on EEG by Independent Component Analysis in Patients With Creutzfeldt-Jakob Disease
  41. CHARACTERISTICS AND OUTCOMES FOR ASSISTED LIVING RESIDENTS WITH DEMENTIA: COMPARING DEMENTIA-SPECIFIC CARE UNITS WITH NON–DEMENTIA-SPECIFIC CARE UNITS
  42. P2-206: Clinical characteristics of new and established sporadic Creutzfeldt-Jakob disease phenotypes
  43. Sexual Behaviors in People With Dementia Living in Long-Term Care: A Retrospective Pilot Study
  44. Clinical Correlates of Personality Changes Associated With Traumatic Brain Injury
  45. Improper Sexual Behaviors in Elders with Dementia Living in Residential Care
  46. Clinical Correlates of Personality Changes Associated With Traumatic Brain Injury
  47. The association between activity participation and time to discharge in the assisted living setting
  48. Acetylcholinesterase inhibitors in assisted living: patterns of use and association with retention
  49. Effect of Dementia and Treatment of Dementia on Time to Discharge from Assisted Living Facilities: The Maryland Assisted Living Study
  50. Epidemiology of Apathy in Older Adults: The Cache County Study
  51. A comparison of small and large assisted living facilities for the diagnosis and care of dementia: the Maryland Assisted Living Study
  52. Authors' reply
  53. Correlates of Caregiver-Rated Quality of Life in Assisted Living: The Maryland Assisted Living Study
  54. Predictors of Caregiver Unawareness and Nontreatment of Dementia Among Residents of Assisted Living Facilities: The Maryland Assisted Living Study
  55. Cerebrovascular disease and dementia
  56. The cerebrovascular disease basis of psychiatric syndromes: A model for the power of disease reasoning in psychiatry
  57. Population-Based Study of Medical Comorbidity in Early Dementia and “Cognitive Impairment, No Dementia (CIND)”: Association With Functional and Cognitive Impairment: The Cache County Study
  58. Clinical application of operationalized criteria for ?Depression of Alzheimer's Disease?
  59. Dr. Onyike and Colleagues Reply
  60. P2-247 A population based study of medical co-morbidity in early dementia and mild cognitive syndrome: association with functional and cognitive impairment
  61. Mania During Treatment of Chronic Hepatitis C With Pegylated Interferon and Ribavirin
  62. Epidemiology of Adult Psychiatric Visits to U.S. Emergency Departments
  63. A randomized, controlled, clinical trial of activity therapy for apathy in patients with dementia residing in long-term care
  64. Is Obesity Associated with Major Depression? Results from the Third National Health and Nutrition Examination Survey
  65. Persistence of the Interaction of Calmodulin with Adenylyl Cyclase: Implications for Integration of Transient Calcium Stimuli
  66. Sequence-dependent interactions between transient calcium and transmitter stimuli in activation of mammalian brain adenylyl cyclase
  67. Analysis of sequence-dependent interactions between transient calcium and transmitter stimuli in activating adenylyl cyclase in Aplysia: possible contribution to CS--US sequence requirement during conditioning.
  68. Faculty of 1000 evaluation for Sensitivity of current criteria for the diagnosis of behavioral variant frontotemporal dementia.
  69. Faculty of 1000 evaluation for Frontotemporal brain sagging syndrome: an SIH-like presentation mimicking FTD.
  70. Faculty of 1000 evaluation for Eating and hypothalamus changes in behavioral-variant frontotemporal dementia.
  71. Faculty of 1000 evaluation for Sensitivity and specificity of FTDC criteria for behavioral variant frontotemporal dementia.
  72. Faculty of 1000 evaluation for Utilisation behaviour in frontotemporal dementia.
  73. Faculty of 1000 evaluation for Rate of change of functional abilities in frontotemporal dementia.
  74. Faculty of 1000 evaluation for Survival profiles of patients with frontotemporal dementia and motor neuron disease.
  75. Faculty of 1000 evaluation for Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration.
  76. Faculty of 1000 evaluation for The Ekman 60 Faces Test as a diagnostic instrument in frontotemporal dementia.
  77. Faculty of 1000 evaluation for The effects of oxytocin on social cognition and behaviour in frontotemporal dementia.
  78. Faculty of 1000 evaluation for Visual rating versus volumetry to detect frontotemporal dementia.
  79. Faculty of 1000 evaluation for Pathological correlates of frontotemporal lobar degeneration in the elderly.
  80. Faculty of 1000 evaluation for Differential Longitudinal Decline on the Mini-Mental State Examination in Frontotemporal Lobar Degeneration and Alzheimer Disease.
  81. Faculty of 1000 evaluation for Slowly progressive frontotemporal lobar degeneration caused by the C9ORF72 repeat expansion: a 20-year follow-up study.
  82. Faculty of 1000 evaluation for Oxytocin for frontotemporal dementia: a randomized dose-finding study of safety and tolerability.
  83. Faculty of 1000 evaluation for A neuropsychological battery to detect specific executive and social cognitive impairments in early frontotemporal dementia.
  84. Faculty of 1000 evaluation for Frontotemporal dementia presenting as schizophrenia-like psychosis in young people: clinicopathological series and review of cases.
  85. Faculty of 1000 evaluation for Cognitive impairment in the preclinical stage of dementia in FTD-3 CHMP2B mutation carriers: a longitudinal prospective study.
  86. Faculty of 1000 evaluation for Morbid risk for schizophrenia in first-degree relatives of people with frontotemporal dementia.
  87. Faculty of 1000 evaluation for Risk factors in late adolescence for young-onset dementia in men: a nationwide cohort study.